Industry Experts

Feny Gunawan is a Senior Director of CMC at Mediar Therapeutics, where she leads CMC strategy and execution for three clinical-stage programs. She brings over 20 years of experience in analytical development and CMC leadership across large molecule biologics, with deep expertise spanning monoclonal and bispecific antibodies, control strategy design, and global regulatory submissions. Feny has led programs from early to late stage development and has extensive experience managing CDMOs, driving comparability strategies, and delivering phase-appropriate CMC solutions for complex biologics.